- Beiersdorf AG is forecasting 1996 growth in group sales of 8% over the 5.35 billion Deutschemarks ($3.58 billion) reported in 1995. A slight improvement in net profits over the 1995 level of 227.1 million is expected. Group sales in the first nine months of 1996 rose 8.2% to 4.4 billion marks with international sales up 11.4%. German sales rose by only 2.9%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze